Skip to main content

ENSAMBLAJE Y MADURACION DE LA SUBUNIDAD PEQUEÑA DE LOS RIBOSOMAS EN EUCARIOTAS

BFU2017-88192-P

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pol5 is an essential ribosome biogenesis factor required for 60S ribosomal subunit maturation in Saccharomyces cerevisiae

  • Ramos-Sáenz, Ana
  • González-Álvarez, Daniel
  • Rodríguez-Galán, Olga
  • Rodríguez-Gil, Alfonso
  • Gaspar, Sonia G.
  • Villalobo, Eduardo
  • Dosil, Mercedes
  • Cruz, Jesús de la
© 2019 Ramos-Sáenz et al., In Saccharomyces cerevisiae, more than 250 trans-acting factors are involved in the maturation of 40S and 60S ribosomal subunits. The expression of most of these factors is transcriptionally coregulated to ensure correct ribosome production under a wide variety of environmental and intracellular conditions. Here, we identified the essential nucleolar Pol5 protein as a novel trans-acting factor required for the synthesis of 60S ribosomal subunits. Pol5 weakly and/or transiently associates with early to medium pre-60S ribosomal particles. Depletion of and temperature-sensitive mutations in Pol5 result in a deficiency of 60S ribosomal subunits and accumulation of half-mer polysomes. Both processing of 27SB pre-rRNA to mature 25S rRNA and release of pre-60S ribosomal particles from the nucle(ol)us to the cytoplasm are impaired in the Pol5-depleted strain. Moreover, we identified the genes encoding ribosomal proteins uL23 and eL27A as multicopy suppressors of the slow growth of a temperature-sensitive pol5 mutant. These results suggest that Pol5 could function in ensuring the correct folding of 25S rRNA domain III; thus, favoring the correct assembly of these two ribosomal proteins at their respective binding sites into medium pre-60S ribosomal particles. Pol5 is homologous to the human tumor suppressor Myb-binding protein 1A (MYBBP1A). However, expression of MYBBP1A failed to complement the lethal phenotype of a pol5 null mutant strain though interfered with 60S ribosomal subunit biogenesis., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and ERDF to J.d.l.C. (BFU2016-75352-P AEI/FEDER, EU) and to M.D. (BFU2014-52729-P, BFU2017-88192-P). D.G.-A. is a recipient of a contract of the Youth Employment Initiative from the University of Seville/Junta de Andalucía/European Social Fund.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of distinct maturation steps involved in human 40S ribosomal subunit biosynthesis

  • Nieto, Blanca
  • Gaspar, Sonia G.
  • Moriggi, Giulia
  • Pestov, Dimitri G.
  • Bustelo, Xosé R.
  • Dosil, Mercedes
Technical problems intrinsic to the purification of preribosome intermediates have limited our understanding of ribosome biosynthesis in humans. Addressing this issue is important given the implication of this biological process in human disease. Here we report a preribosome purification and tagging strategy that overcomes some of the existing technical difficulties. Using these tools, we find that the pre-40S precursors go through two distinct maturation phases inside the nucleolus and follow a regulatory step that precedes late maturation in the cytoplasm. This regulatory step entails the intertwined actions of both PARN (a metazoan-specific ribonuclease) and RRP12 (a phylogenetically conserved 40S biogenesis factor that has acquired additional functional features in higher eukaryotes). Together, these results demonstrate the usefulness of this purification method for the dissection of ribosome biogenesis in human cells. They also identify distinct maturation stages and metazoan-specific regulatory mechanisms involved in the generation of the human 40S ribosomal subunit., M.D. is supported by grants from the Spanish Ministry of Science, Innovation and Universities (BFU2014-52729-P, BFU2017-88192-P) and the Samuel Solórzano Foundation (FS/36-2017). X.R.B. is supported by grants from the Castilla-León Government (CSI049U16), the Spanish Ministry of Science, Innovation and Universities (SAF2015-64556-R), Worldwide Cancer Research (14-1248), the Ramón Areces Foundation, and the Spanish Association against Cancer (GC16173472GARC). B.N. and G.M. have been supported by predoctoral contracts sponsored by the University of Salamanca and Santander Bank, and S.G.G. by a predoctoral FPU contract of the Spanish Ministry of Education, Culture, and Sports. The Centro de Investigación del Cáncer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla-León Government (CLC-2017-01). Both Spanish and Castilla-León government-associated funding is partially supported by the European Regional Development Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Efficient fractionation and analysis of ribosome assembly intermediates in human cells

  • Nieto, Blanca
  • Gaspar, Sonia G.
  • Sapio, Russell T.
  • Clavaín, Laura
  • Bustelo, Xosé R.
  • Pestov, Dimitri G.
© 2021 The Author(s)., Biochemical studies of the human ribosome synthesis pathway have been hindered by technical difficulties in obtaining intact preribosomal complexes from internal regions of the nucleolus. Here we provide a detailed description of an extraction method that enables efficient detection, isolation, and characterization of nucleolar preribosomes containing large pre-rRNA species. The three-step Preribosome Sequential Extraction (PSE) protocol preserves the integrity of early preribosomal complexes and yields preparations amenable to biochemical analyses from low amounts of starting material. We validate this procedure through the detection of specific trans-acting factors and pre-rRNAs in the extracted preribosomes using affinity matrix pull-downs and sedimentation assays. In addition, we describe the application of the PSE method for monitoring cellular levels of ribosome-free 5S RNP complexes as an indicator of ribosome biogenesis stress. Our optimized experimental procedures will facilitate studies of human ribosome biogenesis in normal, mutant and stressed-cell scenarios, including the characterization of candidate ribosome biogenesis factors, preribosome interactors under specific physiological conditions or effects of drugs on ribosome maturation., This work was supported by the Spanish Ministry of Science and Innovation [BFU2017-88192-P to MD][RTI2018-096481-B-100 to XRB]; the National Institutes of Health [R03CA246009 to DGP]; the Castilla-León autonomous government [CSI252P18 and CSI145P2 to XRB]; the Spanish Association against Cancer [GC16173472GARC to XRB]; “la Caixa” Banking Foundation [HR20-00164 to XRB]; and the Samuel Solórzano Foundation [FS/36-2017 to MD]. BN has been supported by a predoctoral contract sponsored by the University of Salamanca and Santander Bank, SGG by a predoctoral FPU contract of the Spanish Ministry of Education, Culture and Sports, and LC by a predoctoral contract from the Spanish Association against Cancer. The Centro de Investigación del Cáncer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla-León Government (CLC-2017-01). Both the Spanish and Castilla-León government-associated funding is partially supported by the European Regional Development Fund.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ribosomal protein deficiencies linked to Diamond-Blackfan anemia induce distinctive alterations of ATF4 expression

  • Lorenzo-Martín, L. Francisco
  • Robles-Valero, Javier
  • Ramírez-Cota, Rosa
  • Gaspar, Sonia G.
  • Fuentes, Pedro
  • Gentilella, Antonio
  • Bustelo, Xosé R.
  • Dosil, Mercedes
Ribosomal protein haploinsufficiency causes Diamond-Blackfan anemia (DBA) and other ribosomopathies. DBA has been linked to p53 activation and reduced GATA1 expression, but these mechanisms do not fully explain the disease. This study unveils that deficiencies in small (RPS) or large (RPL) ribosomal subunit proteins cause a p53-independent loss of ATF4, a master regulator of stress responses and erythropoiesis, by reducing the pool of actively translating ATF4 mRNAs. This defect is more pronounced in RPS deficiencies because the loss of 40S, but not 60S, subunits cause a destabilization of ATF4 transcripts. ATF4 downregulation occurs in early hematopoietic progenitors and correlates with the severity of erythroid differentiation defects in patients with DBA. It is also linked to the de-repression of fetal hemoglobin in erythroid cells, a frequent feature in patients with DBA. Our findings indicate that impaired ATF4 expression might be a primary contributor to DBA and explain the aggravated erythroid failure of RPS-mutant patients., M.D. research has been financed by grants BFU2017-88192-P and PID2020-118378GB-I00, both of them co-funded by MCIN/AEI/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union. X.R.B. has received funding from the Castilla-León government (CSI145P20, CSI018P23), grants co-funded by MCIN/AEI/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union (PID2021-122666OB-I00, PDC2022-133027-I00, PLEC2022-009217), “la Caixa” Banking Foundation (HR20-00164), and the Programa Excelencia of the Fundación Científica AECC 2022 (EPAEC222641CICS). J.R.-V. received funding from the Carlos III Health Institute (PI20/01724). M.D. and X.R.B. center was supported by the Programas de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Castilla-León government (CLC-2017-01 and CL-EI-2021-02) that were both co-funded by the European Research Development Fund., Peer reviewed